Switzerland's Roche will acquire its U.S. collaboration partner Poseida Therapeutics in a cash deal worth up to $1.5 billion, ...

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

LPX-TI641, a therapy to promote immune system balance in MS and other autoimmune diseases, was assessed at varying doses in a ...

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

Cancer continues to be one of the most challenging diseases to treat worldwide. The three main methods used to treat cancer are surgical excision, chemotherapy, and radiation therapy. Immunotherapy ...

What if fighting the onset of dementia was as simple as a few sniffs? Researchers at Texas A&M have discovered a new therapy ...

When it comes to cell therapy, Alloplex Biotherapeutics Inc. CEO Frank Borriello said he believes that autologous, personalized therapy is the only thing that makes sense. “The allure of an ...

Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...